Research and publications
Implemented source adapters include PubMed, Europe PMC, Crossref, and preprint services bioRxiv and medRxiv. Preprints are early research records and should not be treated as peer-reviewed findings.
Trust
The source is part of the product, not a footnote.
Helixera is designed to keep provenance visible: what the source is, what changed, when Helixera observed it, and where to inspect the original record.
What Helixera watches
Coverage depends on source availability, access terms, ingestion health, and the diseases currently supported.
Clinical trials
ClinicalTrials.gov records provide public study identities, status, sponsor, phase, interventions, locations, and other registry fields when available.
Regulatory and public records
Implemented adapters include openFDA/FDA records, FDA drug labels, SEC EDGAR filings, and NIH RePORTER project records.
Companies and trusted publications
Company newsroom and investor-relations pages, BioSpace, I AM ALS, and other approved sources can be monitored with automated or editorial workflows depending on the source.
How a record becomes intelligence
1
Collect
An adapter or approved editorial workflow observes a source record.
2
Normalize
Helixera maps it to a disease, category, source, date, and stable identity.
3
Review signals
Duplicate, source trust, and editorial checks help prepare a publishable update.
4
Publish with provenance
The intelligence view preserves a path to the original source.
Trust boundaries
Source-linked
Important details should be checked in the original source, especially before research or care decisions.
Time-sensitive
Registries, publications, and company records can change after Helixera observes them.
Not uniformly human-reviewed
Helixera includes editorial workflows, but does not promise that every automated item is reviewed by a person before display.